IL135210A0 - Metalloproteinase inhibitors - Google Patents

Metalloproteinase inhibitors

Info

Publication number
IL135210A0
IL135210A0 IL13521097A IL13521097A IL135210A0 IL 135210 A0 IL135210 A0 IL 135210A0 IL 13521097 A IL13521097 A IL 13521097A IL 13521097 A IL13521097 A IL 13521097A IL 135210 A0 IL135210 A0 IL 135210A0
Authority
IL
Israel
Prior art keywords
methoxysuccinamide
pyridin
isobutyl
propyl
hydroxy
Prior art date
Application number
IL13521097A
Other languages
English (en)
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of IL135210A0 publication Critical patent/IL135210A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL13521097A 1997-11-13 1997-11-13 Metalloproteinase inhibitors IL135210A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1997/003132 WO1999025693A1 (en) 1997-11-13 1997-11-13 Metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
IL135210A0 true IL135210A0 (en) 2001-05-20

Family

ID=10807699

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13521097A IL135210A0 (en) 1997-11-13 1997-11-13 Metalloproteinase inhibitors

Country Status (21)

Country Link
EP (1) EP1030842B1 (da)
JP (1) JP2001523666A (da)
KR (1) KR100485479B1 (da)
AT (1) ATE236126T1 (da)
AU (1) AU740420B2 (da)
BR (1) BR9714934A (da)
CA (1) CA2310593C (da)
DE (1) DE69720554T2 (da)
DK (1) DK1030842T3 (da)
ES (1) ES2195122T3 (da)
GB (1) GB2333524A (da)
HU (1) HUP0002811A3 (da)
IL (1) IL135210A0 (da)
NO (1) NO315702B1 (da)
NZ (1) NZ503642A (da)
PL (1) PL189542B1 (da)
PT (1) PT1030842E (da)
RU (1) RU2198164C2 (da)
TR (1) TR200001353T2 (da)
TW (1) TW474919B (da)
WO (1) WO1999025693A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2024507C1 (ru) * 1991-11-18 1994-12-15 Евгений Яковлевич Левитин 5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность
PT822186E (pt) * 1994-01-20 2000-08-31 British Biotech Pharm L-tert-leucina-2-piridilamida
WO1997003966A1 (en) * 1995-07-19 1997-02-06 British Biotech Pharmaceuticals Limited N-(amino acid) substituted succinic acid amide derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
NO20002480L (no) 2000-05-12
PL340494A1 (en) 2001-02-12
EP1030842A1 (en) 2000-08-30
DE69720554T2 (de) 2004-01-08
WO1999025693A1 (en) 1999-05-27
ATE236126T1 (de) 2003-04-15
AU740420B2 (en) 2001-11-01
CA2310593A1 (en) 1999-05-27
DE69720554D1 (de) 2003-05-08
PL189542B1 (pl) 2005-08-31
TW474919B (en) 2002-02-01
GB2333524A (en) 1999-07-28
TR200001353T2 (tr) 2000-10-23
PT1030842E (pt) 2003-07-31
KR20010031879A (ko) 2001-04-16
HUP0002811A3 (en) 2002-11-28
NZ503642A (en) 2001-10-26
NO20002480D0 (no) 2000-05-12
RU2198164C2 (ru) 2003-02-10
EP1030842B1 (en) 2003-04-02
JP2001523666A (ja) 2001-11-27
CA2310593C (en) 2007-05-08
ES2195122T3 (es) 2003-12-01
BR9714934A (pt) 2000-10-03
AU4958497A (en) 1999-06-07
NO315702B1 (no) 2003-10-13
DK1030842T3 (da) 2003-07-28
GB9816317D0 (en) 1998-09-23
KR100485479B1 (ko) 2005-04-27
HUP0002811A2 (hu) 2001-01-29

Similar Documents

Publication Publication Date Title
ITMI921601A1 (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
NZ501277A (en) -2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
IL133623A0 (en) Antithrombotic agents
EP0999834A4 (en) ANTITHROMOSIS
ES2149350T3 (es) Compuestos y liposomas farmaceuticamente activos y metodos para su utilizacion.
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
ATE269089T1 (de) Verwendung von vitamin d derivaten zur verstärkung der wirkung von zytotoxischen stoffen
DE69827236D1 (en) Matrix-metalloproteinase-hemmer
TR200001846T2 (tr) İştah bastırıcı aktiviteye sahip farmasötik kompozisyonlar
DE69015736D1 (de) 7-Keto- und 7-Hydroxy-androsta-3,5-dien-3-carbonsäure Derivate.
NZ301645A (en) (R)-(-)-methyl phenyl oxazolidinone derivatives, pharmaceutical preparations and use for treating TNF stimulated diseases
RU94036771A (ru) Ингибиторы ангиогенеза и ангиогенных заболеваний
RU94037235A (ru) Ингибитор фиброза матки
RU94044454A (ru) Ингибитор аутоимунных заболеваний
EP0627442A4 (en) DERIVATIVE OF A LEWIS TYPE SUGAR CHAIN.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
IL135210A0 (en) Metalloproteinase inhibitors
NZ233704A (en) Dehydrocholecalciferol derivatives, pharmaceutical compositions thereof
ITPD920145A1 (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
AU640647B2 (en) 3-butenamide derivatives
EA200400096A1 (ru) Применение корриноидов при кожных заболеваниях
DE69414396D1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
BR9906975A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero
MX9706283A (es) Nuevos antibioticos de polieno, 3874 hi a h6, procedimientos para su preparacion y empleo.
MX9706086A (es) Preparaciones farmaceuticas para inhibicion de tnf.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees